A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Systemic Lupus Erythematosus
Clinical trial NCT06429800 · WITHDRAWN
Trial details
- NCT number
- NCT06429800
- Sponsor
- Atara Biotherapeutics
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-16
- Primary completion
- 2025-04-16
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.